SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for ...

Spruce Biosciences (OTC:SPRB) has received approval from The Nasdaq Stock Market to resume trading of its common stock on the Nasdaq Capital Market, subject to Spruce regaining compliance with ...

For decades, private capital was a black box, reserved for a select few. Investments happened behind closed doors, data was ...

SSR Mining Inc. (NASDAQ:SSRM) is one of the best stocks to buy amid gold rally. On July 18, BMO Capital Markets resumed coverage on SSR Mining with a “Market Perform” rating and set a price target of ...

Spruce Biosciences, Inc. (OTC: SPRB) (“Spruce”), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet ...

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need ...